Trial Information

Hepatitis B Vaccine for Type 2 Diabetics

Are you interested in learning how you may be able to prevent getting a Hepatitis B infection?

You may not realize that having Type 2 diabetes puts you at greater risk of contracting Hepatitis B. In fact, in 2011, the U.S. Advisory Committee on Immunization Practices recommended that all Type 2 patients be vaccinated against Hepatitis B. Clinical Research Associates in Nashville is enrolling people with Type 2 diabetes in a research study. You may receive the Hepatitis B vaccination at no charge.

The study lasts a total of 7 months. Five office visits are required. You will be given a series of 3 vaccinations. You are guaranteed to receive the Hepatitis B vaccine. There are no placebos (inactive ingredients).

Patient Inclusion Criteria:

Be at least 20 years old
Have been diagnosed with Type 2 diabetes within last 5 years
Not have had the Hepatitis B vaccine previously

Patient Exclusion Criteria:

People who have already had any dose of the Hepatitis B vaccine are not eligible to participate. In addition, if you've had Type 2 diabetes for over 5 years, you are not eligible.

Melissa Carro, Director of Marketing
Clinical Research Associates, Inc.
1500 Church Street
Nashville, TN 37203
Phone: 615-329-2222 ext. 304
Fax: 615-320-7883
Email: melissa@clinicalresearchassociates.com

View Map

Research Center Information: Clinical Research Associates, Inc.

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:
Message:

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.